anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 **
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 **
產(chǎn)品型號: 16-5179-82
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關文檔
簡單介紹
anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 **
anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 **
的詳細介紹
anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 **
產(chǎn)品名稱：anti-human ILT7, novel pDC marker, CD85g FG Purified eBio17G10.2 (17G10.2) 100 ug
產(chǎn)品貨號：eBioscience 16-5179-82
產(chǎn)品規(guī)格：100 ug
Anti-Human CD85g (ILT7) Functional Grade Purified
Also known as: ILT-7, LILRA4
Clone: eBio17G10.2 (17G10.2)
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 16-5179
Cat. No. Size
16-5179-82 100 ug
Description: The eBio17G10.2 monoclonal antibody reacts with human immunoglobulin-like transcript 7 (ILT7), also known as CD85g. ILT7 is part of the leukocyte immunoglobulin-like receptor (LIR) gene family and associates with Fc epsilon R1 gamma to form a functional complex which transduces ITAM-mediated signals that negatively modulates TLR-induced type I IFN production by human plasmacytoid dendritic cells. ILT7 is expressed exclusively on plasmacytoid dendritic cells and is absent in monocyte derived DCs. Treatment with IL-3 or CpG causes a decrease in expression.
Double staining of human PBMCs with eBio17G10.2 and anti-pDC marker BDCA2 yields virtually complete co-staining. Cross linking of ILT7 with eBio17G10.2 antibody causes reduced transcription of IFN alpha1, IFN alpha2, IFN alpha4 and IFN beta.
